Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions
L-asparaginases (EC 3.5.1.1) are a family of enzymes that catalyze the hydrolysis of L-asparagine to L-aspartic acid and ammonia. These proteins with different biochemical, physicochemical and pharmacological properties are found in many organisms, including bacteria, fungi, algae, plants and mammals. To date, asparaginases from E. coli and Dickeya dadantii (formerly known as Erwinia chrysanthemi) are widely used in hematology for the treatment of lymphoblastic leukemias. However, their medical use is limited by side effects associated with the ability of these enzymes to hydrolyze L-glutamine, as well as the development of immune reactions. To solve these issues, gene-editing methods to introduce amino-acid substitutions of the enzyme are implemented. In this review, we focused on molecular analysis of the mechanism of enzyme action and to optimize the antitumor activity.
Top-30
Journals
|
1
2
3
4
|
|
|
International Journal of Molecular Sciences
4 publications, 11.43%
|
|
|
International Journal of Biological Macromolecules
3 publications, 8.57%
|
|
|
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry
2 publications, 5.71%
|
|
|
Frontiers in Pharmacology
2 publications, 5.71%
|
|
|
Biomeditsinskaya Khimiya
2 publications, 5.71%
|
|
|
Applied Sciences (Switzerland)
1 publication, 2.86%
|
|
|
Processes
1 publication, 2.86%
|
|
|
Frontiers in Medicine
1 publication, 2.86%
|
|
|
Journal of Genetic Engineering and Biotechnology
1 publication, 2.86%
|
|
|
Catalysts
1 publication, 2.86%
|
|
|
Journal of Agricultural and Food Chemistry
1 publication, 2.86%
|
|
|
Heliyon
1 publication, 2.86%
|
|
|
Biological Products Prevention Diagnosis Treatment
1 publication, 2.86%
|
|
|
Applied Biochemistry and Microbiology
1 publication, 2.86%
|
|
|
Applied Biochemistry and Biotechnology
1 publication, 2.86%
|
|
|
Separation and Purification Technology
1 publication, 2.86%
|
|
|
Immunology
1 publication, 2.86%
|
|
|
Russian Chemical Reviews
1 publication, 2.86%
|
|
|
Biochemistry (Moscow)
1 publication, 2.86%
|
|
|
Biocatalysis and Biotransformation
1 publication, 2.86%
|
|
|
Biochemistry
1 publication, 2.86%
|
|
|
ACS Catalysis
1 publication, 2.86%
|
|
|
Cancer Gene Therapy
1 publication, 2.86%
|
|
|
Current Opinion in Immunology
1 publication, 2.86%
|
|
|
Bratislava Medical Journal
1 publication, 2.86%
|
|
|
Frontiers in Immunology
1 publication, 2.86%
|
|
|
1
2
3
4
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 publications, 22.86%
|
|
|
MDPI
7 publications, 20%
|
|
|
Frontiers Media S.A.
4 publications, 11.43%
|
|
|
Pleiades Publishing
4 publications, 11.43%
|
|
|
American Chemical Society (ACS)
3 publications, 8.57%
|
|
|
Springer Nature
3 publications, 8.57%
|
|
|
Institute of Biochemistry
2 publications, 5.71%
|
|
|
SCEEMP
1 publication, 2.86%
|
|
|
Wiley
1 publication, 2.86%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 2.86%
|
|
|
Taylor & Francis
1 publication, 2.86%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.